- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 36.84M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 37.6M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 42.77M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $51.59M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $34.9M |
| Capex | Q1 2026 · Mar 31, 2026 | $33.13M |
| Capex | Q1 2026 · Mar 31, 2025 | $25.62M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $29.95M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $20.61M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $718.26M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $717.82M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $148.81M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $148.69M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $519.72M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $573.78M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.72B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.75B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.82B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.81B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $863.72M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.07B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.67B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.91B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.44B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.37B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.39B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.66B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.59 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.57 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.59 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.57 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $46.64M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $43.16M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $13.64M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $13.92M |
| Net Income | Q1 2026 · Mar 31, 2026 | $22.26M |
| Net Income | Q1 2026 · Mar 31, 2025 | $24.24M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $2.93M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $14.47M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $44.32M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $40.4M |
| Revenue | Q1 2026 · Mar 31, 2026 | $267.64M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $272.82M |